Pfizer unveils data from Phase 1b gene therapy clinical trial to treat DMD
The preliminary data from the clinical study of nine ambulatory boys with DMD demonstrated positive results for the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 May 20
The preliminary data from the clinical study of nine ambulatory boys with DMD demonstrated positive results for the…
15 May 20
The approval is based on results of from Phase 3 ECHELON-2 trial, which showed that treatment with ADCETRIS…
14 May 20
Remdesivir is an investigational medicine that has been granted the US Food and Drug Administration (FDA) EUA to…
14 May 20
KEYTRUDA is a humanised monoclonal antibody designed to block the interaction between PD-1 to activate the T lymphocytes
13 May 20
Moderna designed the new mRNA-1273 is an mRNA vaccine to work against SARS-CoV-2 encoding for a prefusion stabilised…
12 May 20
Lynparza is an advanced PARP inhibitor and the targeted treatment to block DNA damage response (DDR) in cells…
12 May 20
Thermo Fisher’s $180m expansion project would increase its commercial viral vector capacity by more than double and support…
11 May 20
The FDA indicated Retevmo for treating a type of RET fusion-positive NSCLC, RET-mutant MTC, RET fusion-positive thyroid cancer…
11 May 20
With the regulatory approval, Entyvio becomes the only maintenance therapy for Crohn’s disease, with both intravenous and subcutaneous…
08 May 20
ZYUS will leverage its bio-pharmaceutical plant technology platform and expertise to develop and express VIDO-InterVac’s protein